SCHEMBL1892909

SCHEMBL1892909

CC(C)(C)OC(=O)C(=Cc1ccccc1)C(=O)c1cc2ccccc2cc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.43
KMT2A Q03164 7/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 4/20 0.38
NR1H4 Q96RI1 1/20 0.38
MITF O75030 1/20 0.38
GAA P10253 1/20 0.38
NCOA1 Q15788 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
CASP3 P42574 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
LMNA P02545 2/20 0.36
RECQL P46063 1/20 0.36
ATM Q13315 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1892906 1.00 MEN1 (0.43) MEN1KMT2ASMN1; SMN2MAPTNR1H4
SCHEMBL1893667 0.84 ABCG2 (0.53) MEN1KMT2ASMN1; SMN2MAPTNR1H4
SCHEMBL1893666 0.84 ABCG2 (0.53) MEN1KMT2ASMN1; SMN2MAPTNR1H4
SCHEMBL1893669 0.84 ABCG2 (0.53) MEN1KMT2ASMN1; SMN2MAPTNR1H4
SCHEMBL1887498 0.84 MEN1 (0.48) MEN1KMT2ASMN1; SMN2MAPTNR1H4
SCHEMBL1887496 0.84 MEN1 (0.48) MEN1KMT2ASMN1; SMN2MAPTNR1H4
SCHEMBL1887493 0.84 MEN1 (0.48) MEN1KMT2ASMN1; SMN2MAPTNR1H4
SCHEMBL1893795 0.84 KMT2A (0.46) MEN1KMT2AMAPTNR1H4NPC1
SCHEMBL1893794 0.84 KMT2A (0.46) MEN1KMT2AMAPTNR1H4NPC1
SCHEMBL1893797 0.84 KMT2A (0.46) MEN1KMT2AMAPTNR1H4NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110117649-A1 Catalytic enantioselective synthesis of flavanones and chromanones NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-05-19 US disclosed
US-7851640-B2 Catalytic enantioselective synthesis of flavanones and chromanones NORTHWESTERN UNIVERSITY (US) 2010-12-14 US disclosed
US-20090259055-A1 Catalytic enantioselective synthesis of flavanones and chromanones NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-10-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259055-A1 Catalytic enantioselective synthesis of flavanones and chromanones RNGTT, CDK20, TBXAS1 MEN1 4332/4885KMT2A 2596/4885SMN1; SMN2 3463/4885
US-20110117649-A1 Catalytic enantioselective synthesis of flavanones and chromanones RNGTT, CDK20, TBXAS1 MEN1 4332/4885KMT2A 2596/4885SMN1; SMN2 3463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.